- Report
- August 2025
- 187 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 191 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 189 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 198 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 182 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 184 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 191 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 195 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- August 2025
- 192 Pages
Global
From €3150EUR$3,545USD£2,715GBP
€3500EUR$3,939USD£3,017GBP
- Report
- March 2025
- 144 Pages
Global
From €2665EUR$2,999USD£2,297GBP
- Report
- April 2025
- 307 Pages
Global
From €3999EUR$4,500USD£3,446GBP
- Report
- July 2025
- 250 Pages
Global
From €3990EUR$4,490USD£3,439GBP
- Report
- April 2025
- 200 Pages
Global
From €3990EUR$4,490USD£3,439GBP
- Report
- April 2025
- 200 Pages
Global
From €3990EUR$4,490USD£3,439GBP
- Report
- February 2025
- 200 Pages
Global
From €3990EUR$4,490USD£3,439GBP
- Report
- February 2025
- 200 Pages
Global
From €3990EUR$4,490USD£3,439GBP
- Report
- August 2025
- 266 Pages
Global
From €5198EUR$5,850USD£4,480GBP
- Report
- August 2025
- 168 Pages
Global
From €5198EUR$5,850USD£4,480GBP
- Report
- August 2025
- 180 Pages
Global
From €5198EUR$5,850USD£4,480GBP
- Report
- August 2025
- 194 Pages
Global
From €5198EUR$5,850USD£4,480GBP

Iodine-131 (I-131) is a radioactive isotope of iodine used in nuclear medicine and radiopharmacology. It is used to diagnose and treat a variety of conditions, including thyroid cancer, hyperthyroidism, and Graves' disease. I-131 is also used to treat certain types of cancer, such as lymphoma and neuroblastoma. It is administered orally, intravenously, or by inhalation. The radiation emitted by I-131 is absorbed by the body and used to destroy cancer cells.
I-131 is produced in nuclear reactors and cyclotrons. It is then purified and formulated into a variety of products, such as capsules, solutions, and suspensions. These products are then distributed to hospitals, clinics, and other healthcare facilities.
The I-131 market is highly regulated, with strict safety and quality standards in place. The market is also subject to fluctuations in supply and demand, as well as changes in the cost of production.
Some companies in the I-131 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Jubilant Radiopharma, and Bracco Diagnostics. Show Less Read more